Arkolith/Insider Trading/RLMD/Form 4

Kelly Paul Edward

DirectorRELMADA THERAPEUTICS, INC. (RLMD) · full profile →Form 4 · filed May 29, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 24, 2024Grant(A)44K—$0109K
May 24, 2024Other(J)44K—$066K

Transaction Codes

A
Grant / award
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-047637) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML